Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies

  • Anja Schweizer, Dejager, James Foley, Kothny
  • Vascular Health and Risk Management, February 2011, Taylor & Francis
  • DOI: 10.2147/vhrm.s16925

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr James E Foley and Dr Sylvie Dejager